AI and Ozempic: The two great disruptive technologies of 2023
Listen now
Description
AI is poised to upend the music industry, and Fast Company Associate Editor David Salazar joins us to discuss what AI generative music is and how the music industry is combating it. Antidiabetic medication Ozempic is all over the news these days, but it's not as new as it seems. Beyond the TikTok trends and celebrity shout-outs, it's been used to treat diabetes for years. But now talk of this medication has reached a fever pitch. Found CEO Sarah Jones Simmer talks about how her company prioritizes comprehensive weight care management, the ongoing discussion about Ozempic, and the very complicated history of weight in this country. Basically, how do we thread the needle between self-acceptance and positive body image and the existing health challenges, like the skyrocketing rates of diabetes? Then we discuss Barbenheimer because, well, we have to.
More Episodes
One in five American workers have signed a noncompete clause in their employment contract, and many likely had no idea what they were agreeing to. Noncompete clauses typically prevent workers from joining competitors for a certain period of time after their employment; and although many people...
Published 06/03/24
Published 06/03/24
Should you send an email, or is Slack the better way to communicate with your colleagues? Is it ever okay to text a client? Can you use emojis with your boss—and if you can, should you? Communication at work can be really fraught and depends on the subject matter, your industry, your company...
Published 05/27/24